VB holdings could represent 24% upside potential



Looking at the underlying ETF holdings in our coverage universe on ETF Channel, we compared the trading price of each holding to the 12-month futures analyst average target price, and calculated the weighted average implied analyst target price. for the ETF itself. For the Vanguard Small-Cap ETF (Symbol: VB), we found that the analysts’ implied target price for the ETF based on its underlying holdings is $223.87 per share.

With VB trading at a recent price close to $179.97 per share, this means analysts see 24.39% upside potential for this ETF when looking at the average analyst targets of the underlying holdings. Three of VB’s underlying holdings with a notable advantage over their analyst target prices are Latham Group Inc (Symbol: SWIM), Coursera Inc (Symbol: COUR) and Alignment Healthcare Inc (Symbol: ALHC). Although SWIM traded at a recent price of $3.15/share, the average analyst target is 76.57% higher at $5.56/share. Similarly, COUR is up 74.69% from the recent stock price of $11.22 if the average analyst target price of $19.60/share is reached, and analysts expect average for the ALHC to reach a target price of $19.39/share, which is 71.12% above the recent price of $11.33. Below is a 12 month price history chart comparing the performance of SWIM, COUR and ALHC stocks:

Table of relative performance SWIM, COUR and ALHC

Below is a table summarizing the current target prices of the analysts mentioned above:

Last name Symbol Recent Price Avg. 12-MB Analyst. Target % increase over target
Vanguard Small Cap ETF VB $179.97 $223.87 24.39%
Latham Group Inc. SWIM $3.15 $5.56 76.57%
Coursera Inc. COURT $11.22 $19.60 74.69%
Alignment Health Inc ALHC $11.33 $19.39 71.12%

Are analysts justified in these targets, or too optimistic about where these stocks will trade in 12 months? Do the analysts have a valid rationale for their goals, or are they lagging behind recent company and industry developments? A high price target relative to a stock’s price can reflect optimism about the future, but can also be a precursor to target price declines if targets were a relic of the past. These are questions that require further investor research.

10 ETFs with the Most Benefits for Analyst Goals »

Also see:

• Industrial equity hedge funds are buying
• AUID Year-to-Date Performance
• Institutional holders of PMCS

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



Back to top button